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The relationship between cytokine concentrations
and wound healing in chronic venous ulceration
Manjit S. Gohel, MB, MRCS,a Robin A. J. Windhaber, MSc, MRCS,b John F. Tarlton, PhD,b
Mark R. Whyman, MS, FRCS,a and Keith R. Poskitt, MD, FRCS,a Gloucestershire and Bristol,
United Kingdom
Objective:The importance of wound cytokine function in chronic venous leg ulcers remains poorly understood. This study
evaluated the relationship between local and systemic concentrations of wound cytokines and wound healing in patients
with chronic venous ulceration.
Methods: This prospective observational study was set in a community- and hospital-based leg ulcer clinic. Consecutive
patients with chronic leg ulceration and ankle-brachial pressure index>0.85 were prospectively investigated. All patients
were treated with multilayer compression bandaging. Wound fluid and venous blood samples were collected at
recruitment and 5 weeks later. In the wound fluid and venous blood, cytokines and factors reflecting the processes of
inflammation (interleukin 1, tumor necrosis factor-), proteolysis (matrix metalloproteinases-2 and -9), angiogenesis
(basic fibroblast growth factor [bFGF], vascular endothelial growth factor), and fibrosis (transforming growth factor-1
[TGF1]) were measured. Ulcer healing was assessed using digital planimetry at both assessments.
Results: The study comprised 80 patients (43 men, 37 women). Median (range) ulcer size reduced from 4.4 (0.1-142.4)
cm2 to 2.2 (0-135.5) cm2 after 5 weeks (P< .001; Wilcoxon signed rank), although 17 of 80 ulcers increased in size. The
volume of wound fluid collected strongly correlated with ulcer size (Spearman rank 0.801, P< .01). Initial wound fluid
concentrations of bFGF correlated with ulcer size (Pearson coefficient  0.641, P < .01), and changes in wound fluid
TGF1 concentrations inversely correlated with changes in ulcer size (Spearman rank  0.645, P  .032). There were
no significant correlations between changes in other factors and ulcer healing. Wound fluid and serum cytokine
concentrations correlated poorly.
Conclusion:Wound fluid collection volume correlates with ulcer size. Ulcer healing correlated with increased concentra-
tions of TGF1, possibly reflecting increased fibrogenesis in the proliferating wound. Aside from this, there was a large
variation in wound and serum cytokine levels that largely limits their usefulness as markers of healing. (J Vasc Surg 2008;
48:1272-7.)The assessment and treatment of patients with chronic
venous ulceration remains a massive clinical and economic
burden for health care providers.1,2 It is widely accepted
that the skin changes that culminate in lower limb ulcer-
ation are a direct result of chronic venous hypertension,3
although the precise pathophysiologic mechanisms are
widely disputed. Theories describing fibrin cuff formation4
and growth factor trapping5 have failed to gain widespread
support. Although favored, the white-cell trapping hypoth-
esis proposed by Coleridge-Smith et al6 fails to provide a
complete explanation.
The complex and multiple processes leading to wound
healing are controlled by cytokines and growth factors
within the healing wound. Numerous researchers have
speculated that further assessment of these factors may yield
important clues regarding failed wound healing and indeed
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1272may indicate specific growth factor deficiencies. On the
basis of such hypotheses, numerous topical growth factor
preparations, including GM-CSF, bFGF (see Table I for
abbreviation expansions), and others, have been proposed
as potentially efficacious therapies, although reproducible
studies demonstrating clinical benefits are scarce.7-9
The development and use of topical factors for thera-
peutic use has not been based on a sound understanding of
venous ulcer pathophysiology or cytokine function. Inflam-
matory markers such as IL1 and TNF have been shown to
be present in significantly higher levels in chronic venous
ulcers than in acute healing wounds.10-12 Similar observa-
Table I. Abbreviations used in the text
Abbreviation Expansion
ABPI Ankle-brachial pressure index
bFGF Basic fibroblast growth factor
ELISA Enzyme-linked immunosorbent assay
GM-CSF Granulocyte macrophage colony stimulating
factor
IL1 Interleukin 1
MMP Matrix metalloproteinase
TGF1 Transforming growth factor-1
TNF Tumour necrosis factor-
VEGF Vascular endothelial growth factortions have been reported for angiogenic factors such
y pro
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consensus exists for the optimum technique for sampling or
measuring these cytokines, and the huge heterogeneity of
cytokine levels has limited the benefit of previous research.
Nevertheless, improved understanding of cytokine and
growth factor dysfunction in chronic venous ulceration
may inspire new therapeutic pathways. The aim of the
present study was to test the hypothesis that local and
systemic cytokine concentrations relate to wound healing
in patients with chronic venous ulceration.
METHODS
Patients and setting. The study was performed within
the setting of an established nurse-led specialist leg ulcer
service in Gloucestershire, United Kingdom. Consecutive
new and follow-up patients with open ulceration between
the ankle and knee and an ABPI 0.85 were targeted.
Patients with duplex evidence of venous reflux were in-
cluded, and a goal of 80 patients was planned. The study
was granted full approval by the Gloucestershire Research
Ethics Committee.
All patients were treated with nonadhesive dressings
(NA, Johnson & Johnson, New Brunswick, NJ) and mul-
tilayer compression bandaging (Profore, Smith &Nephew,
Hull, UK) providing 40 mm Hg of pressure at the ankle
and 17 mm Hg at the calf. For patients with bilateral leg
ulceration, the limb with the largest ulcerated area was
studied. All bandaging was applied by trained staff, and no
treatments were altered or withdrawn on account of partic-
ipation in this study. Patient compliance with compression
therapy was recorded.
Assessments. A relevant medical history and clinical
examination were performed in all patients. No assessments
of leg edema were performed. Venous reflux was assessed
using a Sonos color venous duplex scanner (Hewlett Pack-
ard MPG, Andover, Mass) performed by accredited vascu-
lar technicians.15 Wound fluid and venous blood samples
were collected and standardized digital photographs were
taken. Ulcer areas were calculated from digital photographs
using planimetry software (Mouseyes, Dr R. J. Taylor,
Salford, UK). In cases where wound edges were difficult to
define, the planimetry process was independently verified
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Fig 1. Flow diagram summarizes the studby a second researcher. Wound fluid sampling, venousblood tests, and digital photography were repeated after 5
weeks. The study protocol is summarized in Fig 1.
Venous blood sampling. Venous blood samples were
taken from the antecubital fossa with standard antiseptic
precautions. Samples were immediately centrifuged at
13,000g for 10 minutes to obtain the serum fraction, and
serum aliquots were stored at80°C until use. In addition
to cytokine and growth factor assays, levels of renal func-
tion and inflammatory markers were assessed.
Wound fluid collection. Wound fluid collection was
performed using a standard protocol, as described previ-
ously.12,16 In brief, the ulcerated area was covered by
Tegaderm, a clear adhesive dressing (3M, St. Paul, Minn).
The patient was asked to keep the leg dependent in the
seated position, and any fluid accumulated under the dress-
ing after 90 minutes was aspirated using a hypodermic
needle and syringe (Fig 2). The collected fluid was kept
under ice and centrifuged within 30minutes at 13,000g for
10 minutes to separate particulate matter. Aliquots were
Week 4-6 
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tocol. ABPI, ankle-brachial pressure index.
Fig 2. Photograph demonstrates wound fluid sample collected
under transparent adhesive dressing.T 1
y 
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widely believed to reflect the processes of inflammation
(TNF, IL1), angiogenesis (bFGF, VEGF), fibrogenesis/
fibroblast proliferation (TGF1), and proteolysis (MMP2,
MMP9) were chosen to give a broad assessment of wound
biological activity. With the exception of MMP2 and
MMP9, all assays were performed using a sandwich ELISA
technique (R & D Systems, London, UK). MMP2 and
MMP9 were measured using gelatin zymography, as de-
scribed previously.17 In brief, appropriately diluted samples
were loaded on a polyacrylamide gel copolymerized with
gelatin and electrophoresed at 100 V. Gels were stained
with Coomassie blue, and bands were quantified using
digital software.
Data analysis. All data were stored on an Access data-
base (Microsoft Corp, Redmond, Wash) and analyzed us-
ing SPSS 13.0.1 software (SPSS Inc, Chicago, Ill). Corre-
lations between ulcer healing and changes in cytokine levels
were tested using Pearson and Spearman rank tests for
parametric and nonparametric data, respectively.
RESULTS
Between February 1, 2004, and March 10, 2005, 268
consecutive patients were screened for this study, of which
80 consented to inclusion (Fig 3). The median age was 74
years (range, 36-93 years), and ulcers were present for
median of 3 months (range 1-180 months). The CEAP
grades (level II) for the 80 patients were C6sEp in 68 and
C6sEs in 12. Other demographic variables for the study
population are presented in Table II. Both assessments
were attended by 74 (93%) of the 80 patients. No patients
in the study had signs of soft tissue infection, and all were
compliant with compression bandaging for the duration of
this study.
Clinical progression. Complete ulcer healing was
seen in 12 of 74 (16%) by the 5-week assessment, and a
further 45 (61%) reduced in size during the study period.
Ulcer size increased in 17 participants (23%).
Collection of wound exudates. Successful wound
Fig 3. Details of patients screened, excluded, and recruited for
the study. ABPI, ankle-brachial pressure index.fluid collection was achieved in 52 of 80 patients (65%) atassessment 1 and 34 of 74 (46%) at assessment 2. Failure to
collect wound fluid was caused by a healed or dry ulcer in
65 of 68 occasions, although in three cases fluid was present
but leaked out under the dressing. The median (range)
volume of wound exudates collected was 0.23 (0-2.0) mL
at assessment 1 and 0.23 (0-6.5) mL at assessment 2. The
size of the ulcer correlated strongly with the volume of
exudate collected (Spearman   0.686, P  .001).
Initial serum and wound cytokine concentrations.
Concentrations of IL1, TNF, and bFGF were not de-
tected in serum samples and were excluded from further
analyses. Concentrations of the other cytokines are re-
ported in Table III. In general, the range of cytokine levels
was large within the study population. A significant positive
correlation between ulcer size and initial concentration of
wound fluid bFGF was present (Fig 4). However, there was
no relationship between the initial concentrations of any of
the measured factors and subsequent wound healing.
Changes in serum and wound cytokine concen-
trations. Changes in the serum levels of VEGF negatively
correlated with patient age, meaning that older patients had
the lowest increases (or greatest decreases) in serum VEGF
from 0 to 5 weeks (Spearman  0.321, P .01). When
the wound fluid cytokine changes and wound healing over
the duration of the study was compared, only TGF1
changes correlated significantly with changes in ulcer size
(Table IV). Healing ulcers were associated with an increase
in wound fluid concentrations of TGF1.
DISCUSSION
This study confirmed that wound fluid collection is
Table II. Demographic variables and details of venous
reflux for study population
Variable No. or median (range)
Patient, No. 80
Age, years 75 (40-93)
Sex
Male 43
Female 37
Ulcer chronicity, months 3 (1-180)
BMI, kg/m2 27.6 (19.3-64.9)
Diabetes mellitus 10
Previous DVT 12
Ulcer size, cm2 4.7 (0.1-142.4)
Venous reflux
Isolated superficial
GSV only 27
SSV only 12
GSV and SSV 6
Perforators only 5
Isolated deep 4
Deep and superficial
Deep and GSV 13
Deep and SSV 4
Deep and GSV and SSV 9
BMI, Body mass index; DVT, deep venous thrombosis; GSV, great saphe-
nous vein; SSV, small saphenous vein.often unsuccessful and is significantly more likely in larger
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higher in the larger ulcers. Concentrations of VEGF corre-
lated inversely with patient age, and TGF1 levels in the
wound fluid increased during venous ulcer healing, possibly
reflecting the greater fibrogenesis, matrix deposition, and
proliferation in the healing wound. Whether extrinsic
TGF1 administration would enhance venous ulcer healing
requires further investigation.
Wound cytokine concentrations have been assessed
previously by a number of researchers, and comparisons
between acute and chronic wounds have clearly demon-
strated a massive increase in proinflammatory cytokines
(TNF and IL1).12,18 Moreover, the levels of MMP2,
MMP9, and other proteases have consistently been shown
Table III. Cytokine concentrations at assessment 1 for
the study population
Cytokinea Initial level (range)
Serum
proMMP9, % stdb 51.3 (7.2-449.9)
proMMP2, % stdb 28.7 (0-114.7)
VEGF, pg/mL 165 (21.2-1315.0)
Wound fluid
proMMP9, % stdb 280.1 (33.4-829.1)
proMMP2, % stdb 21.1 (2.7-193.4)
IL1, pg/mL 17,877 (864-85,848)
TNF, pg/mL 767 (92-26,160)
BFGF, pg/mL 228 (65-1370)
VEGF, pg/mL 2950 (130-18580)
TGF1, pg/mL 114 (33-771)
aSee Table I for abbreviation expansions.
bMMP concentrations expressed as a percentage of an MMP2 standard
sample used for all assays.
Pearson coefficient 0.641, 
P<.01
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Fig 4. Scatter plot demonstrates the significant correlation be-
tween wound fluid levels of basic fibroblast growth factor (bFGF)
and ulcer size.to be higher in chronic wounds compared with acutewounds.19-21 Although protease changes were mapped
over time for the patients with venous ulcers in one study,17
few studies have assessed changes in other cytokines and
factors over time in chronic wounds. Studies by Trengove
et al16 assessed wound fluid protease concentrations before
and after 2 weeks of inpatient leg elevation and demon-
strated lower levels of MMP2 and MMP9 and proinflam-
matory cytokines in healing ulcers. These findings were not
reproduced in our study; however, the influence of outpa-
tient compression therapy may differ from inpatient eleva-
tion.
Although patient recruitment for clinical trials for ve-
nous ulceration is notoriously challenging, the sample size
for this study was significantly larger than other comparable
studies. The inclusion criteria were deliberately very open,
and consecutive eligible patients were approached to ensure
that the target population was truly representative of the
entire leg ulcer population.
A number of previous studies have investigated cyto-
kines in venous ulcers, but few have evaluated the practical
difficulties and reliability of such assessments. In this study,
the success of sample collection, reasons for failure, and
comparisons between different sampling modalities were
primary objectives in addition to cytokine measurements.
Despite practical limitations, the trial methodology was
carefully planned to ensure a scientifically robust study
design.
Unfortunately, paired wound fluid analysis was only
possible in 43% of recruited patients. Studies by Trengove
et al12 and Murphy et al18 did not report any difficulties
with wound fluid collection, although ulcer sizes were
larger than in the current study population. Most of these
failures in sample collection were due to practical factors:
Ulcers were often dry and did not produce fluid. The
effectiveness of compression therapy may have contributed
to failed wound fluid collection. However, successful fluid
collections were achieved in healing ulcers, where compres-
sion therapy was presumably effective. An alternative
Table IV. Relationship between changes in wound
cytokines and ulcer healing from 0 to 5 weeks
Cytokinea
Correlation of cytokine and ulcer
size changes Pb
Serum
proMMP9 0.193 .110
proMMP2 0.201 .098
VEGF 0.131 .304
Wound fluid
proMMP9 0.194 .296
proMMP2 0.151 .462
ILI 0.028 .931
TNF 0.100 .713
bFGF 0.127 .726
VEGF 0.146 .565
TGF1 0.645 .032
aSee Table I for abbreviation expansions.
bSpearman rank test.method of wound fluid collection, such as the use of filter
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fluid collections,17 although the tiny volumes collected
would preclude many of the cytokine assessments per-
formed in this study. It should be recognized, however,
that wound fluid assessment is more likely to be represen-
tative in patients with larger venous ulcers rather than for
the entire ulcer population.
Cytokine levels and changes in cytokine levels varied
enormously between different patients. In most cases, the
huge range in measurements did not relate to clinical
criteria, meaning that same level of a specific cytokinemight
be normal for one individual but highly abnormal for
another. General conclusions are therefore difficult to
draw, although paired assessments were used to partly
combat these population variations. In view of the hetero-
geneity among the study patients, the failure to study both
ulcerated legs in patients with bilateral ulcers may represent
a missed opportunity in this study.
An assumption of the study is that measured cytokines
directly reflect the chronic wound, whereas the influence of
other illnesses or nonpathologic behaviors on cytokine
concentrations is unclear. Cytokine analysis was performed
using venous blood and wound fluid samples in this study,
but whether these samples are actually representative of the
wound bed is simply not known. Nor is it clear if cytokine
or factor secretion into the wound fluid or absorption into
the blood stream is consistent over time. Some authors
have suggested that that protease release may vary in differ-
ent parts of the same wound, but this has not been widely
substantiated.17
Wound fluid TGF1 was the only measured cytokine
that mirrored venous ulcer healing. Unfortunately, paired
analyses were only possible for the 46% of participants with
successful paired wound fluid collection, meaning that
these changes might only be applicable to patients with
larger ulcers. A negative correlation with ulcer size was
identified, although these findings may simply reflect the
changes of the healing and deteriorating venous wound. An
alternative explanation is that the lack of progression in the
deteriorating wounds is secondary to a deficiency in
TGF1. Whether the relationship between TGF1 and
ulcer healing is causal or consequential remains unknown.
A clinical trial investigating the influence of extrinsic
TGF1 supplementation may resolve this point. Unfortu-
nately, such a study is unlikely to be supported in the near
future because this type of product may take years to
develop and trials of other extrinsic growth factors have
yielded little clinical benefit.9
CONCLUSIONS
This study demonstrated that cytokine assessment in
chronic venous ulcers is associated with practical sampling
difficulties and huge interpatient variation in cytokine con-
centrations. In this study population, concentrations of
TGF1 in wound fluid mirrored ulcer healing. The rela-
tionship between wound cytokines and venous ulceration
was otherwise poor. Further studies are required to confirmthe validity of these findings and explore potential clinical
applications.
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